SynthesisThe Cochrane database of systematic reviews2022

Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis.

Graziella Filippini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.